Propiverine: Difference between revisions
No edit summary |
No edit summary |
||
Line 50: | Line 50: | ||
| StdInChIKey = QPCVHQBVMYCJOM-UHFFFAOYSA-N | | StdInChIKey = QPCVHQBVMYCJOM-UHFFFAOYSA-N | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | |||
==Overview== | |||
'''Propiverine''' is an [[anticholinergic]] drug used for the treatment of urinary urgency, frequency and urge incontinence, all symptoms of overactive bladder syndrome. It is a [[muscarinic antagonist]].<ref>British Medical Journal Group and Pharmaceutical Press (2011). BNF 61, ISBN 978 0 85369 962 0, CPI Clausen & Bosse, Leck, Germany, p511.</ref> A modified release preparation is also available, taken once daily. | '''Propiverine''' is an [[anticholinergic]] drug used for the treatment of urinary urgency, frequency and urge incontinence, all symptoms of overactive bladder syndrome. It is a [[muscarinic antagonist]].<ref>British Medical Journal Group and Pharmaceutical Press (2011). BNF 61, ISBN 978 0 85369 962 0, CPI Clausen & Bosse, Leck, Germany, p511.</ref> A modified release preparation is also available, taken once daily. | ||
==References== | ==References== | ||
{{reflist}} | {{reflist|2}} | ||
{{Urologicals}} | {{Urologicals}} | ||
Line 62: | Line 67: | ||
[[Category:Ethers]] | [[Category:Ethers]] | ||
[[Category:Carboxylate esters]] | [[Category:Carboxylate esters]] | ||
[[Category:Drug]] | |||
Revision as of 15:24, 10 April 2015
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | |
Pharmacokinetic data | |
Elimination half-life | 20.1 h |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C23H29NO3 |
Molar mass | 367.481 g/mol |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
WikiDoc Resources for Propiverine |
Articles |
---|
Most recent articles on Propiverine Most cited articles on Propiverine |
Media |
Powerpoint slides on Propiverine |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Propiverine at Clinical Trials.gov Clinical Trials on Propiverine at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Propiverine
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Propiverine Discussion groups on Propiverine Patient Handouts on Propiverine Directions to Hospitals Treating Propiverine Risk calculators and risk factors for Propiverine
|
Healthcare Provider Resources |
Causes & Risk Factors for Propiverine |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Propiverine is an anticholinergic drug used for the treatment of urinary urgency, frequency and urge incontinence, all symptoms of overactive bladder syndrome. It is a muscarinic antagonist.[1] A modified release preparation is also available, taken once daily.
References
- ↑ British Medical Journal Group and Pharmaceutical Press (2011). BNF 61, ISBN 978 0 85369 962 0, CPI Clausen & Bosse, Leck, Germany, p511.
- Pages with script errors
- Template:drugs.com link with non-standard subpage
- Articles with changed ChemSpider identifier
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles with changed InChI identifier
- Chemical articles with unknown parameter in Infobox drug
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- Piperidines
- Anticholinergics
- Ethers
- Carboxylate esters
- Drug